Loading...
Sulfoglycodendrimer Therapeutics for HIV‐1 and SARS‐CoV‐2
Hexavalent sulfoglycodendrimers (SGDs) are synthesized as mimics of host cell heparan sulfate proteoglycans (HSPGs) to inhibit the early stages in viral binding/entry of HIV‐1 and SARS‐CoV‐2. Using an HIV neutralization assay, the most promising of the seven candidates are found to have sub‐micromol...
Na minha lista:
| Udgivet i: | Adv Ther (Weinh) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995185/ https://ncbi.nlm.nih.gov/pubmed/33786368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adtp.202000210 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|